Vitamin E and Alzheimer's Disease-Is It Time for Personalized Medicine?

Overview

Journal Antioxidants (Basel)

Date 2017 Jul 5

PMID 28672782

Citations 15

Authors

Breana Cervantes

Lynn M Ulatowski

Affiliations

Soon will be listed here.

Abstract

For the last two decades, it has been hotly debated whether vitamin E-the major lipid-soluble antioxidant, which functions to maintain neurological integrity-is efficacious as a therapy for Alzheimer's disease. Several factors key to the debate, include (1) which of the eight naturally-occurring vitamin E forms should be used; (2) how combination treatments affect vitamin E efficacy; and (3) safety concerns that most-recently resurfaced after the results of the Selenium and vitamin E Cancer prevention trial SELECT prostate cancer trial. However, with the advent of new genetic technologies and identifications of vitamin E-modulating single nucleotide polymorphisms (SNPs), we propose that clinical trials addressing the question "Is vitamin E an effective treatment for Alzheimer's disease" should consider a more focused and personalized medicine approach to designing experiments. An individual's naturally-occurring SNP variants may indeed influence vitamin E's therapeutic effect on Alzheimer's disease.

Citing Articles

Enjoy Carefully: The Multifaceted Role of Vitamin E in Neuro-Nutrition.

Regner-Nelke L, Nelke C, Schroeter C, Dziewas R, Warnecke T, Ruck T Int J Mol Sci. 2021; 22(18).

PMID: 34576251 PMC: 8466828. DOI: 10.3390/ijms221810087.

Key points for the development of antioxidant cocktails to prevent cellular stress and damage caused by reactive oxygen species (ROS) during manned space missions.

Gomez X, Sanon S, Zambrano K, Asquel S, Bassantes M, Morales J NPJ Microgravity. 2021; 7(1):35.

PMID: 34556658 PMC: 8460669. DOI: 10.1038/s41526-021-00162-8.

The medicinal chemistry of mitochondrial dysfunction: a critical overview of efforts to modulate mitochondrial health.

Lee M, Mahy W, Rackham M RSC Med Chem. 2021; 12(8):1281-1311.

PMID: 34458736 PMC: 8372206. DOI: 10.1039/d1md00113b.

Controlled Release of the α-Tocopherol-Derived Metabolite α-13'-Carboxychromanol from Bacterial Nanocellulose Wound Cover Improves Wound Healing.

Hoff J, Karl B, Gerstmeier J, Beekmann U, Schmolz L, Borner F Nanomaterials (Basel). 2021; 11(8).

PMID: 34443772 PMC: 8398652. DOI: 10.3390/nano11081939.

Rodent Models of Amyloid-Beta Feature of Alzheimer's Disease: Development and Potential Treatment Implications.

Poon C, Wang Y, Fung M, Zhang C, Lim L Aging Dis. 2020; 11(5):1235-1259.

PMID: 33014535 PMC: 7505263. DOI: 10.14336/AD.2019.1026.

References

Blessed G, Tomlinson B, Roth M . The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968; 114(512):797-811. DOI: 10.1192/bjp.114.512.797. View

Morris M, Evans D, Tangney C, Bienias J, Wilson R, Aggarwal N . Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr. 2005; 81(2):508-14. DOI: 10.1093/ajcn.81.2.508. View

Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M . An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S33-9. View

Feranchak A, Sontag M, Wagener J, Hammond K, Accurso F, Sokol R . Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr. 1999; 135(5):601-10. DOI: 10.1016/s0022-3476(99)70059-4. View

Shi M, Bleavins M, de la Iglesia F . Pharmacogenetic application in drug development and clinical trials. Drug Metab Dispos. 2001; 29(4 Pt 2):591-5. View

Burton G, Traber M . Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr. 1990; 10:357-82. DOI: 10.1146/annurev.nu.10.070190.002041. View

Qian J, Morley S, Wilson K, Nava P, Atkinson J, Manor D . Intracellular trafficking of vitamin E in hepatocytes: the role of tocopherol transfer protein. J Lipid Res. 2005; 46(10):2072-82. DOI: 10.1194/jlr.M500143-JLR200. View

Borel P, Desmarchelier C . Genetic Variations Involved in Vitamin E Status. Int J Mol Sci. 2016; 17(12). PMC: 5187894. DOI: 10.3390/ijms17122094. View

Major J, Yu K, Weinstein S, Berndt S, Hyland P, Yeager M . Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer. J Nutr. 2014; 144(5):729-33. PMC: 3985829. DOI: 10.3945/jn.113.189928. View

10.

Copp R, Wisniewski T, Hentati F, Larnaout A, Ben Hamida M, KAYDEN H . Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res. 1999; 822(1-2):80-7. DOI: 10.1016/s0006-8993(99)01090-2. View

11.

Higashi M, Veenstra D, Kondo L, Wittkowsky A, Srinouanprachanh S, Farin F . Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. JAMA. 2002; 287(13):1690-8. DOI: 10.1001/jama.287.13.1690. View

12.

Morris M, Evans D, Bienias J, Tangney C, Wilson R . Vitamin E and cognitive decline in older persons. Arch Neurol. 2002; 59(7):1125-32. DOI: 10.1001/archneur.59.7.1125. View

13.

Jimenez-Jimenez F, de Bustos F, Molina J, Benito-Leon J, Tallon-Barranco A, Gasalla T . Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease. J Neural Transm (Vienna). 1997; 104(6-7):703-10. DOI: 10.1007/BF01291887. View

14.

Sano M, Ernesto C, Thomas R, Klauber M, Schafer K, Grundman M . A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997; 336(17):1216-22. DOI: 10.1056/NEJM199704243361704. View

15.

Perry G, Cash A, Smith M . Alzheimer Disease and Oxidative Stress. J Biomed Biotechnol. 2002; 2(3):120-123. PMC: 161361. DOI: 10.1155/S1110724302203010. View

16.

Sunderland T, Hill J, Mellow A, Lawlor B, Gundersheimer J, Newhouse P . Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc. 1989; 37(8):725-9. DOI: 10.1111/j.1532-5415.1989.tb02233.x. View

17.

Dysken M, Sano M, Asthana S, Vertrees J, Pallaki M, Llorente M . Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014; 311(1):33-44. PMC: 4109898. DOI: 10.1001/jama.2013.282834. View

18.

Liu Q, Xie F, Rolston R, Moreira P, Nunomura A, Zhu X . Prevention and treatment of Alzheimer disease and aging: antioxidants. Mini Rev Med Chem. 2007; 7(2):171-80. DOI: 10.2174/138955707779802552. View

19.

Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O . Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett. 1997; 409(1):105-8. DOI: 10.1016/s0014-5793(97)00499-7. View

20.

Lloret A, Badia M, Mora N, Pallardo F, Alonso M, Vina J . Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis. 2009; 17(1):143-9. DOI: 10.3233/JAD-2009-1033. View